Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea.

Banamu, J K; Lavu, E; Johnson, K; Moke, R; Majumdar, S S; Takarinda, K C; Commons, R J

Banamu, J K; Lavu, E; Johnson, K; Moke, R; Majumdar, S S; Takarinda, K C; Commons, R J.

Afiliación

Banamu JK; Central Public Health Laboratory, Port Moresby, Papua New Guinea (PNG).
Lavu E; Central Public Health Laboratory, Port Moresby, Papua New Guinea (PNG).
Johnson K; Central Public Health Laboratory, Port Moresby, Papua New Guinea (PNG).
Moke R; Health and HIV Implementation Services Provider, Port Morseby, PNG.
Majumdar SS; Internal Medicine Division, Port Moresby General Hospital, Port Moresby, PNG.
Takarinda KC; Burnet Institute, Melbourne, Victoria, Australia.
Commons RJ; The International Union Against Tuberculosis and Lung Disease, Paris, France.

Public Health Action ; 9(Suppl 1): S19-S24, 2019 Sep 21.

Article en En | MEDLINE | ID: mdl-31579645

Palabras clave

GeneXpert; GxAlert; multidrug-resistant tuberculosis; tuberculosis treatment initiation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Public Health Action Año: 2019 Tipo del documento: Article Pais de publicación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google